BEONE MEDICINES LTD (ONC)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$358.26-1.22%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · ONC
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||
| Revenues | 6,129.0 | 5,343.0 | 3,810.2 | 2,458.8 | 1,415.9 | 1,176.3 | 308.9 | 428.2 | 198.2 | 238.4 | 1.1 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 238.4 | 1.1 |
| Cost of Revenues | — | — | — | — | 286.5 | 164.9 | 70.7 | 71.2 | 28.7 | — | — |
| Gross Profit | 5,448.3 | 4,674.5 | 3,216.2 | 2,078.9 | 1,129.4 | 1,011.4 | — | — | — | — | — |
| Operating Expenses & Income | |||||||||||
| Selling, General & Admin | 2,232.6 | 2,081.5 | 1,831.1 | 1,508.0 | 1,278.6 | 990.1 | 600.2 | 388.2 | 195.4 | 62.6 | — |
| R&D Expenses | 2,292.6 | 2,145.9 | 1,953.3 | 1,778.6 | 1,640.5 | 1,459.2 | 1,294.9 | 927.3 | 679.0 | 269.0 | 98.0 |
| Operating Income | 923.1 | 447.1 | (568.2) | (1,207.7) | (1,789.7) | (1,438.7) | (1,657.7) | (959.9) | (705.8) | (98.5) | (117.1) |
| Earnings from Continuing Operations | |||||||||||
| Interest Expense | — | 58.2 | — | — | — | — | — | — | — | — | — |
| Interest & Investment Income | — | 70.5 | — | 78.4 | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | 868.1 | 416.9 | (533.0) | (825.8) | (1,961.0) | (1,438.6) | (1,618.2) | (943.6) | (689.8) | (91.1) | (119.2) |
| Income Tax Expense | 212.4 | 129.9 | 111.8 | 55.9 | 42.8 | 19.2 | 10.4 | 7.0 | (15.8) | 2.2 | 0.1 |
| Earnings from Continuing Operations | — | — | — | — | — | — | — | — | — | — | (119.2) |
| Net Income | |||||||||||
| Minority Interest | — | — | — | — | 0.0 | 0.0 | (3.6) | (2.0) | (0.3) | (0.2) | (0.3) |
| Net Income | 655.7 | 286.9 | (644.8) | (881.7) | (2,003.8) | (1,457.8) | (1,625.0) | (948.6) | (673.8) | (93.1) | (119.2) |
| Per Share | |||||||||||
| Basic EPS | 0.45 | 0.20 | (0.47) | (0.65) | (1.49) | (1.21) | (1.50) | — | — | — | — |
| Diluted EPS | 0.44 | 0.19 | (0.47) | (0.65) | (1.49) | (1.21) | (1.50) | — | — | — | — |
| Revenue per Share | 4.07 | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 1,450.5 | 1,417.8 | 1,368.7 | 1,357.0 | 1,340.7 | 1,206.2 | 1,085.1 | — | — | — | — |
| Diluted Weighted Avg Shares | 1,505.4 | 1,474.8 | 1,368.7 | 1,357.0 | 1,340.7 | 1,206.2 | 1,085.1 | — | — | — | — |
| Supplemental | |||||||||||
| EBITDA | — | 588.8 | (396.4) | (1,120.1) | (1,723.4) | (1,392.3) | (1,625.9) | (941.3) | (695.4) | (93.7) | — |
| EBIT | 923.1 | 447.1 | (568.2) | (1,207.7) | (1,789.7) | (1,438.7) | (1,657.7) | (959.9) | (705.8) | (98.5) | (117.1) |
| Effective Tax Rate | 24.5% | — | — | -6.8% | -2.2% | -1.3% | -0.6% | -0.7% | 2.3% | -2.5% | -0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.